# FDA Inspection 1047429 - Hysan Pharmaceutical Co., Ltd. - March 29, 2018

Source: https://www.keypedia.com/records/fda_inspections/hysan-pharmaceutical-co-ltd/4c571815-cdb2-4a4c-8a8c-a289b1de074e
Source feed: FDA_Inspections

> FDA Inspection 1047429 for Hysan Pharmaceutical Co., Ltd. on March 29, 2018. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1047429
- Company Name: Hysan Pharmaceutical Co., Ltd.
- Inspection Date: 2018-03-29
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1274837 - 2025-06-12](https://www.keypedia.com/records/fda_inspections/hysan-pharmaceutical-co-ltd/24fb6aa1-34d3-49fe-90bf-23c0c6ba1733)
- [FDA Inspection 941851 - 2015-09-10](https://www.keypedia.com/records/fda_inspections/hysan-pharmaceutical-co-ltd/b393d2c4-d54f-4753-80e6-1523d258448f)
- [FDA Inspection 822258 - 2012-10-11](https://www.keypedia.com/records/fda_inspections/hysan-pharmaceutical-co-ltd/4ecf0660-1a3a-4097-8ce5-feac560365ef)

Company: https://www.keypedia.com/companies/hysan-pharmaceutical-co-ltd/8b76f14f-78cf-44ad-8a25-6d2053566c1a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c